Gland Pharma’s board has approved the appointment of Shyamakant Giri as the new chief executive officer (CEO) of the company.
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...
Dharmesh Kharwar joins Entod Pharmaceuticals as independent director: Our Bureau, Mumbai Saturday, October 19, 2024, 11:30 ...
Shaheen Majeed, global CEO & MD, Sami-Sabinsa Group elected as vice chairman, CII National Committee on IPR: Our Bureau, ...
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...
Our Bureau, Mumbai Saturday, October 19, 2024, 12:30 Hrs [IST] ...
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths: United Kingdom Saturday, October 19, 2024, 13:00 Hrs [IST] The UK go ...
EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities: Nivelles, Belgium Saturday, Oct ...
MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results